We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.14B
AUM Growth
-$171M
Cap. Flow
-$231M
Cap. Flow %
-7.38%
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$29.5M
2
MIDD icon
Middleby
MIDD
+$25.9M
3
PH icon
Parker-Hannifin
PH
+$25.1M
4
VEEV icon
Veeva Systems
VEEV
+$23M
5
DKS icon
Dick's Sporting Goods
DKS
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.38%
2 Energy 14.09%
3 Industrials 13.84%
4 Healthcare 13.22%
5 Consumer Discretionary 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
101
JBT Marel
JBTM
$7.26B
$10M 0.32%
116,588
-27,910
-19% -$2.28M
AORT icon
102
Artivion
AORT
$1.33B
$9.99M 0.32%
521,825
-23,551
-4% -$429K
ON icon
103
ON Semiconductor
ON
$31.6B
$9.75M 0.31%
+763,830
New +$9.12M
XHB icon
104
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
$9.7M 0.31%
286,600
WCC
105
WESCO International
WCC
$15.6B
$9.65M 0.31%
+145,050
New +$9.21M
WPZ
106
DELISTED
Williams Partners L.P.
WPZ
$9.58M 0.31%
251,830
+49,400
+24% +$1.77M
WMGI
107
DELISTED
Wright Medical Group Inc
WMGI
$9.44M 0.3%
410,870
+7,690
+2% +$179K
MDSO
108
DELISTED
Medidata Solutions, Inc.
MDSO
$9.44M 0.3%
190,040
-41,105
-18% -$2.13M
CVSA
109
Covista Inc
CVSA
$4.46B
$9.34M 0.3%
+299,335
New +$8.1M
ZLTQ
110
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$9.34M 0.3%
214,560
-30,990
-13% -$1.25M
VNDA icon
111
Vanda Pharmaceuticals
VNDA
$302M
$9.31M 0.3%
583,960
+118,415
+25% +$1.9M
LNG icon
112
Cheniere Energy
LNG
$54.5B
$9.29M 0.3%
224,250
SU icon
113
Suncor Energy
SU
$77.6B
$9.28M 0.3%
283,850
EGRX
114
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$9.24M 0.29%
+116,520
New +$8.46M
CONE
115
DELISTED
CyrusOne Inc Common Stock
CONE
$9.05M 0.29%
202,330
-65,245
-24% -$2.89M
WAGE
116
DELISTED
WageWorks, Inc.
WAGE
$9.01M 0.29%
124,258
-21,735
-15% -$1.46M
DORM icon
117
Dorman Products
DORM
$4.27B
$8.88M 0.28%
121,525
+1,330
+1% +$90.8K
RAMP icon
118
LiveRamp
RAMP
$2.3B
$8.77M 0.28%
327,385
+32,830
+11% +$852K
XOM icon
119
ExxonMobil
XOM
$657B
$8.75M 0.28%
96,910
OVV icon
120
Ovintiv
OVV
$16.9B
$8.72M 0.28%
148,550
-68,808
-32% -$3.92M
TACO
121
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$8.72M 0.28%
617,490
+157,720
+34% +$2.19M
BHI
122
DELISTED
Baker Hughes
BHI
$8.7M 0.28%
133,900
+90,100
+206% +$5.35M
CSII
123
DELISTED
Cardiovascular Systems, Inc.
CSII
$8.69M 0.28%
358,785
+3,990
+1% +$97.9K
DE icon
124
Deere & Co
DE
$166B
$8.67M 0.28%
84,143
+82,743
+5,910% +$7.78M
ICLR icon
125
Icon
ICLR
$13.6B
$8.67M 0.28%
115,280
-49,455
-30% -$3.84M

Similar funds

Castleark Management's Q4 2016 Portfolio in Review

As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Energy and Industrials.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.

  • Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
  • Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
  • Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
  • Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
  • Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
  • Castleark Management opened 72 new positions and closed 73 in Q4 2016.
  • Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.